化合物 T16711 T16711
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
5 mg | 98206-10-1 | ¥3,730.00 | 询底价 |
50 mg | 98206-10-1 | ¥15,800.00 | 询底价 |
100 mg | 98206-10-1 | ¥23,500.00 | 询底价 |
2 mg | 98206-10-1 | ¥3,190.00 | 询底价 |
25 mg | 98206-10-1 | ¥12,100.00 | 询底价 |
1 mL | 98206-10-1 | ¥4,120.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Flesinoxan
描述: Flesinoxan is a hypotensive agent and is an effective, high affinity, and selective 5-hydroxytryptamine1A receptor agonist (EC50: 24 nM).
体内活性: Flesinoxan acts as a partial agonist at postsynaptic and as a full agonist at presynaptic 5-HT1A receptors. The intravenous administration of Flesinoxan suppresses the firing activity of both CA3 pyramidal neurons and dorsal raphe 5-HT neurons. The capacity of Flesinoxan to antagonize the effect of 5-HT on CA3 pyramidal neurons was similar to that of 8-OH-DPAT. The acute brain penetration of [3H]Flesinoxan and [3H]8-OH-DPAT are determined. Nine minutes after intravenous administration, [3H]8-OH-DPAT reached significantly greater brain concentration than [3H]Flesinoxan. Subcutaneous administration of Flesinoxan and 8-OH-DPAT produce dose-dependent hypothermia. The Flesinoxan-induced hypothermia is significantly attenuated by prior administration of the non-selective 5-HT1A antagonist pindolol and the 5-HT1/2 antagonist methysergide. Similar degrees of hypothermia is achieved with 3 mg/kg of Flesinoxan and 0.5 mg/kg of 8-OH-DPAT. The maximal effect of Flesinoxan occurs 30 min later than that of 8-OH-DPAT and fades more slowly.
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 31.25 mg/mL (75.22 mM)
关键字: Flesinoxan
相关产品: p-MPPI hydrochloride | Azacyclonol | Ricasetron | Triflupromazine hydrochloride | RS 67333 hydrochloride | BMY-14802 hydrochloride | PF-03382792 | Hesperetin | GR 125743 | WAY-100635 Monomaleate
化合物 T16711 T16711信息由TargetMol中国为您提供,如您想了解更多关于化合物 T16711 T16711报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途